Neogenomics Inc.

+1.14 (+3.74%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.89B
Current PE79.76
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$125.89 Million
Adjusted EPS-$0.14
See more estimates
10-Day MA$34.35
50-Day MA$41.97
200-Day MA$44.85
See more pivots

Neogenomics Inc. Stock, NASDAQ:NEO

12701 Commonwealth Drive, Suite 9, Fort Myers, Florida 33913
United States of America
Phone: +1.239.768.0600
Number of Employees: 1700


NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.